BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.420
-0.230 (-6.30%)
Jun 11, 2026, 1:34 PM EDT - Market open
BioAtla Market Cap
BioAtla has a market cap or net worth of $5.67 million as of June 11, 2026. Its market cap has decreased by -74.56% in one year.
Market Cap
5.67M
Enterprise Value
10.18M
1-Year Change
-74.56%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $5.67M, a decrease of -99.94%. That is a compound annual growth rate of -74.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 6.05M | -81.95% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CNS Pharmaceuticals | 6.74M |
| Genprex | 6.73M |
| PMGC Holdings | 6.41M |
| Purple Biotech | 6.36M |
| Can-Fite BioPharma | 6.31M |
| Liminatus Pharma | 6.17M |
| Evogene | 6.03M |
| Enveric Biosciences | 5.96M |